Expired contract

PHE_Scientific_Development of an Ovine Polyclonal Immunoglobulin Therapy.

Details

Value
GBP 26,523
Duration
1 year
Topic
Peptones and protein substances
Published
9 February 2021

Tender description

This requirement was to develop a rapid and effective therapy against infection by developing an ovine immunoglobulin treatment against the spike protein of Covid 19. Additional information: PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak for the research of therapeutic antibodies.

Timeline

  1. Completed: Award date17 April 2020
  2. Completed: Award published9 February 2021
    Current notice
  3. Completed: Contract expiry date16 April 2021

About the buyer

Public Health England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 24956000 · Peptones and protein substances

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Related topics

Topics related to PHE_Scientific_Development of an Ovine Polyclonal Immunoglobulin Therapy., ranked by notice volume.

View all topics
TopicCountValue
  1. 869
    £16.2bn

Related buyers

Buyers similar to Public Health England.

View all buyers

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.